These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1533944)

  • 1. Reanalyzing the reanalysis of femoropopliteal angioplasty.
    Darcy MD
    Radiology; 1992 Jun; 183(3):621-2. PubMed ID: 1533944
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses.
    Cotroneo AR; Pascali D; Iezzi R
    J Endovasc Ther; 2008 Jun; 15(3):283-91. PubMed ID: 18540701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regarding "Stenting for femoropopliteal lesions".
    Schillinger M; Minar E
    J Vasc Surg; 2008 Jul; 48(1):252; author reply 252-3. PubMed ID: 18589243
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous viabahn-assisted subintimal recanalization (VASIR) for severe femoropopliteal occlusive disease.
    Verta MJ; Schneider JR; Alonzo M; Hahn D
    Acta Chir Belg; 2007; 107(2):181-6. PubMed ID: 17515268
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease.
    Davies MG; Waldman DL; Pearson TA
    J Am Coll Surg; 2005 Aug; 201(2):275-96. PubMed ID: 16038827
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: "Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses".
    Parmar V
    J Endovasc Ther; 2008 Oct; 15(5):628-9; author reply 629-30. PubMed ID: 18840055
    [No Abstract]   [Full Text] [Related]  

  • 7. Five-year results of iliac and femoropopliteal angioplasty in diabetic patients.
    Stokes KR; Strunk HM; Campbell DR; Gibbons GW; Wheeler HG; Clouse ME
    Radiology; 1990 Mar; 174(3 Pt 2):977-82. PubMed ID: 2137639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenting in the femoropopliteal arterial segment.
    Mewissen MW
    Tech Vasc Interv Radiol; 2005 Dec; 8(4):146-9. PubMed ID: 16849093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
    J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined iliac transluminal angioplasty and femoropopliteal reconstruction for multilevel arterial occlusive disease.
    Bull PG; Schlegl A; Mendel H
    Int Surg; 1993; 78(4):332-7. PubMed ID: 8175263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evidence for stenting in femoropopliteal occlusive disease.
    Minar E; Schillinger M
    Acta Chir Belg; 2008; 108(3):292-7. PubMed ID: 18710101
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term results of iliac and femoral angioplasty.
    van Andel GJ
    Ann Radiol (Paris); 1981; 24(5):365-8. PubMed ID: 6460457
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic options for femoropopliteal occlusive disease.
    Moore WS
    Circulation; 1991 Feb; 83(2 Suppl):I91-3. PubMed ID: 1825052
    [No Abstract]   [Full Text] [Related]  

  • 14. Short femoropopliteal arterial stenoses: is cutting balloon angioplasty the solution?
    Cotroneo AR; Iezzi R
    Radiology; 2009 Apr; 251(1):304; author reply 304-5. PubMed ID: 19332859
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of radiation therapy in the treatment of femoropopliteal occlusive disease.
    Chellini J; Ansel GM; Botti CF; Silver MJ
    J Invasive Cardiol; 2003 Jan; 15 Suppl A():21A-24A. PubMed ID: 12668838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why endovascular therapy should be utilized before surgical bypass for femoropopliteal occlusive disease.
    Ansel GM; Botti CF; Silver Barry S George MJ; George BS
    J Invasive Cardiol; 2001 Aug; 13(8):608-10. PubMed ID: 11481513
    [No Abstract]   [Full Text] [Related]  

  • 17. Local paclitaxel delivery in peripheral vascular disease.
    Diehm N; Baumgartner I; Jüni P
    N Engl J Med; 2008 May; 358(22):2406-7; author reply 2407. PubMed ID: 18512273
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma homocysteine and restenosis after femoropopliteal angioplasty.
    Kovacevic T; Van Der Loo B; Amann-Vesti BR; Rousson V; Koppensteiner R
    J Endovasc Ther; 2004 Jun; 11(3):302-9. PubMed ID: 15174910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoropopliteal angioplasty with US guidance: an example of a niche market.
    Polak JF
    Radiology; 1996 May; 199(2):317-8. PubMed ID: 8668770
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: a metaanalysis of randomized trials.
    E Y; He N; Wang Y; Fan H
    J Vasc Interv Radiol; 2008 Apr; 19(4):499-503. PubMed ID: 18375292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.